Peter A. Steck
Impact in
- Genetics top 1%
- Glioma Diagnosis and Treatment
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
Papers in
-
- Glycosylation and Glycoproteins Research 12
- PI3K/AKT/mTOR signaling in cancer 9
- RNA modifications and cancer 6
- Protein Tyrosine Phosphatases 6
- Ubiquitin and proteasome pathways 6
- Oncology 10
- Co-authors
- W.K. Alfred Yung (19 shared papers)Huai Lin (5 shared papers)Mark A. Pershouse (10 shared papers)Lauren A. Langford (4 shared papers)Samar A. Jasser (4 shared papers)Sean V. Tavtigian (3 shared papers)Thaylon Davis (2 shared papers)Azra H. Ligon (4 shared papers)
- Journals
- Journal of Neuro-Oncology (5 papers)Oncogene (5 papers)Journal of Biological Chemistry (3 papers)Molecular Carcinogenesis (3 papers)Experimental Cell Research (3 papers)
- Partner nations
- United StatesAustraliaSpain
In The Last Decade
Peter A. Steck
67 papers receiving 5.7k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Genetics 818
- Cancer Research 1.1k
- Molecular Biology 4.4k
- Oncology 1.6k
- Immunology and Allergy 307
Countries citing papers authored by Peter A. Steck
This map shows the geographic impact of Peter A. Steck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Steck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Steck more than expected).
Fields of papers citing papers by Peter A. Steck
This network shows the impact of papers produced by Peter A. Steck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Steck. The network helps show where Peter A. Steck may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter A. Steck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers Hit paper breakdown → | 1997 | 2266 |
| 2 | 1999 | 262 | |
| 3 | Regulation of Akt/PKB activity, cellular growth, and apoptosis in prostate carcinoma cells by MMAC/PTEN. | 1999 | 226 |
| 4 | Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. | 1999 | 221 |
| 5 | Elevated levels of M(r) 92,000 type IV collagenase in human brain tumors. | 1993 | 219 |
| 6 | Adenovirus-mediated transfer of the p53 gene produces rapid and generalized death of human glioma cells via apoptosis. | 1996 | 206 |
| 7 | Adenoviral transgene expression of MMAC/PTEN in human glioma cells inhibits Akt activation and induces anoikis. | 1998 | 182 |
| 8 | Inhibition of angiogenesis in human glioblastomas by chromosome 10 induction of thrombospondin-1. | 1996 | 119 |
| 9 | 1997 | 114 | |
| 10 | 1983 | 111 | |
| 11 | 1997 | 109 | |
| 12 | Antiangiogenesis treatment for gliomas: transfer of antisense-vascular endothelial growth factor inhibits tumor growth in vivo. | 1999 | 102 |
| 13 | 1993 | 97 | |
| 14 | 2000 | 87 | |
| 15 | 1997 | 87 | |
| 16 | Allelic deletion analyses of MMAC/PTEN and DMBT1 loci in gliomas: relationship to prognostic significance. | 1998 | 81 |
| 17 | 1983 | 72 | |
| 18 | 1994 | 69 | |
| 19 | 1997 | 67 | |
| 20 | Analysis of the functional role of chromosome 10 loss in human glioblastomas. | 1993 | 63 |
About Peter A. Steck
Peter A. Steck is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Cancer Research and Genetics, having authored 69 papers that have together received 5.8k indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (12 papers), PI3K/AKT/mTOR signaling in cancer (9 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Cancer Research and Treatments (6 papers), RNA modifications and cancer (6 papers), Protein Tyrosine Phosphatases (6 papers), Ubiquitin and proteasome pathways (6 papers) and Glioma Diagnosis and Treatment (5 papers). The work is most often cited by research in Genetics (818 citations), Cancer Research (1.1k citations), Molecular Biology (4.4k citations), Oncology (1.6k citations) and Immunology and Allergy (307 citations). Peter A. Steck has collaborated with scholars based in United States, Australia and Spain. Frequent co-authors include W.K. Alfred Yung, Huai Lin, Mark A. Pershouse, Lauren A. Langford, Samar A. Jasser, Sean V. Tavtigian, Thaylon Davis, Azra H. Ligon, Cheryl A. Frye and Thomas Hattier. Their work appears in journals such as Journal of Neuro-Oncology, Oncogene, Journal of Biological Chemistry, Molecular Carcinogenesis and Experimental Cell Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.